ARROWHEAD PHARMACEUTICALS, INC. short interest in 2025
In 2025, ARROWHEAD PHARMACEUTICALS, INC.'s disclosed short interest ran from 7.77% of shares outstanding on 15 Jan 2025 to 6.96% on 31 Dec 2025, a change of -0.81 percentage points. The year's high was 10.73% on 30 Apr 2025 and its low 6.96% on 31 Dec 2025, averaging 8.70% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.63 days on 13 Jun 2025. Full history: ARROWHEAD PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 7.77% (15 Jan 2025)
- End of year
- 6.96% (31 Dec 2025)
- Change
- -0.81 pp
- High
- 10.73% (30 Apr 2025)
- Low
- 6.96% (31 Dec 2025)
- Average
- 8.70%
- Highest days to cover
- 8.63 (13 Jun 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 7.77% | 6.14 | |
| 31 Jan 2025 | 8.09% | 2.81 | |
| 14 Feb 2025 | 7.48% | 6.80 | 10-Q filed, results (8-K) |
| 28 Feb 2025 | 7.29% | 7.45 | |
| 14 Mar 2025 | 8.28% | 6.26 | |
| 31 Mar 2025 | 9.50% | 7.07 | |
| 15 Apr 2025 | 9.94% | 5.34 | |
| 30 Apr 2025 | 10.73% | 7.63 | |
| 15 May 2025 | 9.59% | 7.16 | 10-Q filed, results (8-K) |
| 30 May 2025 | 9.64% | 7.46 | |
| 13 Jun 2025 | 9.18% | 8.63 | |
| 30 Jun 2025 | 9.14% | 7.81 | |
| 15 Jul 2025 | 8.99% | 7.92 | |
| 31 Jul 2025 | 9.37% | 5.46 | |
| 15 Aug 2025 | 9.39% | 5.19 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 9.21% | 5.56 | |
| 15 Sep 2025 | 8.58% | 3.55 | |
| 30 Sep 2025 | 8.46% | 4.77 | |
| 15 Oct 2025 | 8.43% | 6.34 | |
| 31 Oct 2025 | 8.52% | 6.82 | |
| 14 Nov 2025 | 8.39% | 7.11 | |
| 28 Nov 2025 | 8.56% | 3.44 | 10-K filed, results (8-K) |
| 15 Dec 2025 | 7.40% | 2.95 | |
| 31 Dec 2025 | 6.96% | 5.33 |
See also: ARROWHEAD PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.